Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fangyi Fan
Observed names:
FANG-YI FAN,
Fang-Yi Fan,
Fang-yi Fan,
Fang‐Yi Fan
Institutions:
North Sichuan Medical University,
Army Medical University,
Xinqiao Hospital,
Chinese People's Liberation Army
Observed institutions:
North Sichuan Medical University,
Army Medical University,
Chengdu Military General Hospital,
Xinqiao Hospital,
Chinese People's Liberation Army
ORCID:
0000-0002-0626-9559
Observed ORCID:
0000-0002-0626-9559
OpenAlex ID:
A5017793966
Facile exfoliation of MoS 2 nanosheets by protein as a photothermal-triggered drug delivery system for synergistic tumor therapy
2016
·
Rui Deng
, Hai Yi
, et al.
·
RSC Advances
·
71
The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma
2017
·
Fang-Yi Fan
, Rui Deng
, et al.
·
International Journal of Oncology
·
37
PDF
[Retracted] The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma
2020
·
Fang-Yi Fan
, Rui Deng
, et al.
·
International Journal of Oncology
·
32
PDF
BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial
2025
·
Hao Yao
, Shi-hui Ren
, et al.
·
Journal of Hematology & Oncology
·
29
PDF
MEG3 affects the progression and chemoresistance of T‐cell lymphoblastic lymphoma by suppressing epithelial‐mesenchymal transition via the PI3K/mTOR pathway
2018
·
Rui Deng
, Fang‐Yi Fan
, et al.
·
Journal of Cellular Biochemistry
·
21
Effect of miR-381-3p/FGF7 axis on the osteogenic differentiation of bone marrow mesenchymal stem cells through MEK/ERK signaling pathway
2022
·
Ling Qiu
, Jiao Cai
, et al.
·
Tissue and Cell
·
20
Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission
2024
·
Xiaojuan Miao
, Yanrong Shuai
, et al.
·
Frontiers in Immunology
·
16
MiR-449a attenuates autophagy of T-cell lymphoma cells by downregulating ATG4B expression
2020
·
Nan Zhang
, Ling Qiu
, et al.
·
BMB Reports
·
15
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
2017
·
Rui Deng
, Fang-Yi Fan
, et al.
·
Experimental and Therapeutic Medicine
·
12
PDF
Prophylactic use of interleukin 6 monoclonal antibody can reduce CRS response of CAR-T cell therapy
2024
·
Baitao Dou
, Shihui Ren
, et al.
·
Frontiers in Medicine
·
11
PDF
PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model
2018
·
Rui Deng
, Fang-yi Fan
, et al.
·
Hematology
·
11
PDF
FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression
2023
·
Nan Zhang
, Meng-yu Shen
, et al.
·
Biochimica et Biophysica Acta (BBA) - General Subjects
·
9
Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy
2023
·
Hao Yao
, Lei Cheng
, et al.
·
Expert Review of Anticancer Therapy
·
6
A Single-Center, Single-Arm, Phase I Clinical Trial of Anti-BCMA/GPRC5D Bispecific CAR T-Cells in Patients with Refractory and Relapsed Multiple Myeloma with Extramedullary Disease
2024
·
Ling Qiu
, Shihui Ren
, et al.
·
Blood
·
4
PDF
Case Report: Bortezomib Plus CDOP Followed by Sequential Autologous Hematopoietic Stem Cell Transplantation and Lenalidomide-Based Maintenance Therapy in Plasmablastic Lymphoma
2021
·
Jiao Cai
, Ling Qiu
, et al.
·
Frontiers in Medicine
·
4
PDF
Infusion of basic fibroblast growth factor ameliorates acute graft versus host disease in mice after haploidentical hematopoietic stem cell transplantation
2015
·
Fangyi Fan
, Li Fu
, et al.
·
Immunology Letters
·
4
Efficacy and safety of BCMA-directed CAR T-cell therapy in extramedullary relapsed or refractory multiple myeloma: a meta-analysis
2026
·
Yan-ling Li
, Meng-jiao Li
, et al.
·
Frontiers in Immunology
·
3
PDF
CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis
2025
·
Ying He
, Ling Qiu
, et al.
·
Frontiers in Immunology
·
3
PDF
Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial
2025
·
Hao Yao
, Shi-hui Ren
, et al.
·
Journal of Hematology & Oncology
·
3
PDF
Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of CHOP plus auto-HSCT
2023
·
Nan Zhang
, Shan Zhang
, et al.
·
Medicine
·
3
Family Aggregation of Hematological Malignancies Discovered from an Acute Myeloid Leukemia Patient with STK11 and THBD Gene Mutation
2023
·
Nan Zhang
, Xiao-juan Miao
, et al.
·
Case Reports in Oncology
·
3
Advances in stem cell-based therapeutics for acute high-altitude illness: research progress and prospects
2025
·
Bai-Tao Dou
, Meng-Jiao Li
, et al.
·
Frontiers in Physiology
·
2
Inhibiting autophagy enhances idarubicin chemosensitivity and induces immune escape in FAT1-low-expressing AML cells
2024
·
Nan Zhang
, Yu-ting Wang
, et al.
·
International Immunopharmacology
·
2
Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis
2023
·
Ling Qiu
, Lei Ma
, et al.
·
Journal of bone oncology
·
2
Whole genome, exon mutation and transcriptomic profiling of acute myeloid leukemia: A case report
2021
·
Si-Han Lai
, Ye-Cheng Li
, et al.
·
Oncology Letters
·
2
PDF
Show more works
View as search
Works count:
37
Citation count:
330
H-index:
11
I10-index:
11
Year
Topic
Type